# OnCo record innovent (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/innovent/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "innovent" ;
  schema:name "Innovent Biologics"@en ;
  schema:alternateName "信达生物"@en, "Innovent Biologics (Suzhou)"@en, "Innovent Biopharmaceutical Technology (Hangzhou)"@en, "Innovent Biologics"@en ;
  schema:description "Innovent makes sintilimab, China's best-selling PD-1 antibody, and has become a source of next-generation assets for Roche and Takeda."@en ;
  schema:url <https://onco.cc/companies/innovent/>, <https://www.innoventbio.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Innovent_Biologics> ;
  owl:sameAs <http://www.wikidata.org/entity/Q106004358> ;
  schema:citation <https://www.innoventbio.com/>, <https://www.innoventbio.com/InvestorsAndMedia/PressReleaseDetail?key=524> ;
  onco:tag "china" ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:drugs <https://onco.cc/drugs/sintilimab/>, <https://onco.cc/drugs/fulzerasib/>, <https://onco.cc/drugs/equecabtagene-autoleucel/>, <https://onco.cc/drugs/ibi354/>, <https://onco.cc/drugs/ibi343/>, <https://onco.cc/drugs/ibi310/>, <https://onco.cc/drugs/ibi363/>, <https://onco.cc/drugs/taletrectinib/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/>, <https://onco.cc/companies/roche-genentech/>, <https://onco.cc/companies/takeda/> ;
  onco:trials <https://onco.cc/trials/nct05923008/>, <https://onco.cc/trials/nct05890742/>, <https://onco.cc/trials/nct05636215/>, <https://onco.cc/trials/nct06083207/>, <https://onco.cc/trials/nct06974812/>, <https://onco.cc/trials/nct05116462/>, <https://onco.cc/trials/nct07722494/>, <https://onco.cc/trials/nct06797297/>, <https://onco.cc/trials/nct06081920/>, <https://onco.cc/trials/nct07483554/>, <https://onco.cc/trials/nct06281678/>, <https://onco.cc/trials/nct07122687/> .